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1. Introduction
The treatment of ascending aorta diseases is usually performed by traditional surgery with
median sternotomy and cardiopulmonary bypass. However, in some patients, the operative
risk of this approach may be prohibitive. In these instances, endovascular approaches to the
ascending aorta may be an alternative.
Endovascular approaches are being increasingly utilized to treat a variety of thoracic aortic
diseases including aneurysms, pseudoaneurysms, dissections, penetrating aortic ulcers,
traumatic aortic rupture, coarctation and abdominal aortic aneurysms [1].
Ascending aorta has several limitations for the endovascular approach, such as its larger
diameter and the presence of the aortic valve and the coronary arteries.
2. Access and technique
The endovascular procedure is usually performed through the femoral arteries [1-3]. Some‐
times this access is impossible or not recommended because of small size vessels, obstruction,
calcification, dissection or extreme tortuosity.
The feasibility of endovascular treatment depends on many anatomic factors, including the
diameter and the disease state of the access vessels [4,5]. Stenosis, calcifications, tortuosity,
small size or dissection in both femoral and iliac arteries can make introduction of large sheath
hazardous or impossible.
© 2013 Saadi et al.; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Endoprosthesis deployment in the ascending aorta usually requires large diameter and long
sheath. There is always possibility of damaging the aortic valve, since the nose of the com‐
mercially available devices is designed for descending and/or abdominal aorta. The vascular
prosthesis should be large enough to oversize by 15-20 % the aortic diameter and short in
length to fit between the coronary arteries and the brachiocephalic trunk. This length usually
measures 8 cm or less. The endovascular technique would have several advantages over the
open surgical alternatives if the right tools for the procedure were available. Current thoracic
aortic stent-grafts are too long, while abdominal aortic stent-grafts are too short and narrow.
Moreover, abdominal aortic delivery systems are too short to traverse the long and tortuous
path from the femoral artery to the ascending aorta.
Several different approaches have been presented and published over the last years as an
attempt to solve very dramatic situations stretching the limits of the current technology [6-8].
The technique should be carefully planned. Rapid pacing and adenosine are useful to lower
blood pressure and allow precise deployment. A rigid (Landerquist or super stiff) and long
(260 cm) guidewire is usually placed in the left ventricle to give adequate support near the
coronary arteries. This is similar to what we use when performing transcatheter aortic valve
implantation (TAVI). One important tip is to perform a “wide J-shape” at the end of the rigid
guidewire in order to prevent left ventricule perforation and, consequently, cardiac tamponade
or left ventricular pseudoaneurysm.
Similar to other endovascular procedures, besides careful planning, patient selection and
technical expertise are crucial to obtain satisfactory results. In this setting multidetector
computed tomography (MDCT) plays an important role in selecting the patients suitable for
the procedure and allows a careful and detailed step by step preoperative planning.
We have recently published a series of five clinical cases and described the technique in which
the axillary artery was used to deliver the endograft for the treatment of different thoracic
aortic diseases [9]. We also demonstrated the possibility of concomitant treatment of ascending
aorta disease and coronary stent implantation [10,11].
Transcarotid is another alternative access and, recently, transapical approach through a small
left thoracotomy has been described.
3. Clinical cases
In this part we will discuss clinical cases of endovascular treatment of ascending aortic diseases
showing different approaches and techniques.
3.1. Clinical case 1
A 32-year-old female presenting cardiogenic shock (Figures 1-2).
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Figure 1. Aortogram showing bovine trunk and a pseudoaneurysm in the anterolateral wall of the ascending aorta 1
cm above the ostium of the right coronary artery.
Figure 2. Final aortogram of emergency endovascular correction of a pseudoaneurysm through transfemoral implan‐
tation of a Cook endoprosthesis. The shorter device we had available was a 8 cm length endoprosthesis. In order to
preserve flow in the brachiocephalic trunk and left carotid artery (bovine trunk) we had to use a chimney (snorkel)
technique in this two vessels arch using two Viabahns to preserve flow.
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3.2. Clinical case 2
A 57-year-old female underwent coronary artery bypass graft in another hospital with left
internal mammary artery to the left anterior descending and saphenous vein graft to the right
coronary artery. The patient developed mediastinitis and had 7 reinterventions resulting in
acute bleeding through the sternum. She was sent to our hospital in cardiogenic shock and
manual compression of the bleeding site in the sternum. Previous computed tomography
showed ruptured pseudoaneurysm at the proximal anastomosis of saphenous vein graft to the
(Figures 3-6).
Figure 3. Emergency endovascular deployment of two abdominal extension cuffs (Gore-Tex) in the ascending aorta
between the coronary ostium and the brachiocephalic trunk through the left axillary artery. The bleeding stopped im‐
mediately and the patient became stable.
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Figure 4. Right coronary angiography demonstrating severe stenosis. Once saphenous vein graft to the right coronary
artery had occluded by the endoprosthesis, the native right coronary artery had to be treated.
Figure 5. Deployment of three stents in the right coronary artery.
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Figure 6. Computed tomography showing the two extension cuffs in the ascending aorta and the three stents in the
right coronary artery.
3.3. Clinical case 3
A 74-year-old male with previous coronary artery bypass graft presented with iatrogenic
ascending aortic pseudoaneurysm that occurred during angiography. The patient was at very
high risk for surgical treatment, therefore an (Figures 7-9).
Figure 7. A) Coronary angiogram showing left main bifurcation with severe stenosis and circumflex with severe steno‐
sis extending to large marginal branch. (B) Aortic angiogram demonstrating ascending aorta dilatation and image
suggesting dissection at the saphenous vein graft ostium.
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Figure 8. Computerized tomographic angiography showing a 3.4-cm pseudoaneurysm with partial thrombosis in as‐
cending aorta and surrounding intramural hematoma.
 
Figure 9. A) Intravascular ultrasound of left main artery evidencing significant stenosis due to calcified plaque. (B) In‐
travascular ultrasound measurements confirming the presence of a large left main artery and significant plaque bur‐
den. (C) Virtual histology showing predominantly fibrous plaque and superficial calcium arch.
Both procedures were successfully performed and the patient was discharged without (Figures
10-12). At 6 months and 1 year clinical follow-up the patient had no symptoms as well as no
other adverse cardiovascular events.
4. Target diseases
There are several pathologies of the ascending aorta that can be potentially addressed by the
endovascular approach. Pseudoaneurysms or sacular aneurysms in the mid-ascending aorta
are adequate for this technique because they usually appear with a sufficient proximal and
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distal landing zone. On the other hand, fusiform aneurysms have the limitation of lacking a
sufficient landing zone in many cases.
Thoracic endovascular stent grafting has revolutionized the treatment of distal [type B] acute
aortic dissection. Endovascular surgeons are now seeking the ways to improve the treatment
of type A dissection by offering endovascular techniques to replace conventional surgical
therapy. Less invasive endovascular therapy, obviates the need for sternotomy and cardio‐
pulmonary bypass, reduces perioperative morbidity, and offers an alternative solution for
Figure 10. Coronary angiogram showing final result in right anterior oblique projection (A) and spider view (B).
Figure 11. (A) Ascending aorta angiogram before endoprosthesis deployment showing a large pseudoaneurysm (yel‐
low arrow). (B) Ascending aorta angiogram after endoprosthesis deployment evidencing sealed pseudoaneurysm and
a type 1 endoleak (red arrow).
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those patients not eligible for conventional intervention due to co-morbidity or severe
complications of the disease.
Thoracic stent grafting in the ascending aorta presents specific challenges and the role of
uncovered stents is unclear in this situation. The majority of patients with acute type A aortic
dissection has the intimal tear originated in the sinotubular junction. More than 90% of patients
with this disease does not have sufficient proximal or distal landing zone required for secure
fixation. Therefore, the site of the intimal tear as well as aortic valve insufficiency and aortic
diameter >38mm are major factors limiting the use of endovascular therapy for acute type A
dissection. Current available stents in use to treat type B aortic dissection do not address
anatomical constraints present in type A aortic dissection in the majority of cases, hence the
development of new devices is required.
5. Technical limitations
Endovascular approach of the ascending aorta has several limitations and is still in its
beginning phase.
The diameter of the ascending aorta is usually larger than the rest of the aorta and the proximity
with the aortic valve and the presence of the coronary arteries pose special challenges.
The length of the delivery system, which is designed for the abdominal aorta, does not allow
to reach the ascending aorta through the groin.
Figure 12. Computerized tomographic angiography showing final result after endoprosthesis deployment.
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Finally, the length of the endoprosthesis itself for descending aorta may be too long to be
positioned between the coronary ostia and the brachiocephalic trunk.
6. Conclusions
Despite the fantastic progress in this field and the clear advantages of endovascular approaches
for the ascending aorta in some clinical situations, one must bear in mind the high level of risk
that these procedures entail.
Long-term data are not available to establish the safety and durability of stent-graft repairs.
The cases described represent an off-label use of this technology and should be considered
with the above mentioned limitations in mind.
The surgeon will need special skills in open aortic surgery and catheter based interventions to
be able to plan the procedure carefully, to properly deliver the devices and to manage the
potential serious complications [12].
Challenges in endograft design are the development of branched endografts and of pathology-
specific endografts [13]. However, the unique composition of the proximal thoracic aorta and
the associated mechanical properties have to be taken into account and make this effort by far
more complex than initially expected. Moreover, there is a need for reducing the stent-graft
devices profile as well as for increasing conformability and trackability.
We believe that  future  advances  with devices  specifically  designed for  the  treatment  of
ascending aorta diseases will  allow this technique to be incorporated into routine medi‐
cal practice.
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